Cargando…

Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report

Palmoplantar psoriasis, a clinical variant of plaque psoriasis, has a significant impact by causing deterioration in the social and functional aspects of patients’ lives. Numerous therapeutic interventions are available for palmoplantar psoriasis. Although emerging biological agents have had an enor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al Muqrin, Abdullah Muqrin, Alghamdi, Abdulaziz A, AlShaalan, Ziad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547619/ https://www.ncbi.nlm.nih.gov/pubmed/36217411 http://dx.doi.org/10.2147/CCID.S384990

Ejemplares similares

Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
por: Daham, Nujud, et al.
Publicado: (2020)

Palmoplantar Psoriasis Successfully Treated With Risankizumab
por: Alajlan, Abdulmajeed M, et al.
Publicado: (2021)

Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: a Report of Two Cases
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Erythrodermic Psoriasis Managed with Risankizumab
por: Alajlan, Abdulmajeed, et al.
Publicado: (2022)

Rapidly and successful improvement of nail psoriasis with risankizumab
por: Orsini, Diego, et al.
Publicado: (2023)

A case of nail psoriasis improved with treatment by risankizumab
por: AlAjlan, Abdulmajeed, et al.
Publicado: (2022)

Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination
por: Al Muqrin, Abdullah M., et al.
Publicado: (2022)

Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience
por: Caldarola, Giacomo, et al.
Publicado: (2023)

Risankizumab for psoriasis
Publicado: (2020)

Mepolizumab induced palmoplantar psoriasis: A case report
por: Artosi, Fabio, et al.
Publicado: (2023)

Mycosis fungoides diagnosed after exposure to risankizumab for psoriasis
por: Fahmy, Lauren M., et al.
Publicado: (2023)

Tozinameran: Exacerbations of generalised pustular psoriasis, palmoplantar psoriasis, and psoriasis vulgaris: 3 case reports
Publicado: (2022)

“Ayurveda management of Palmoplantar Psoriasis (Vipadika) -a case report”
por: Kumar Bhatted, Santosh, et al.
Publicado: (2023)

Secondary Syphilis Presenting As Palmoplantar Psoriasis
por: Gianfaldoni, Serena, et al.
Publicado: (2017)

Risankizumab: COVID-19: case report
Publicado: (2021)

Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report
por: Carriero, Martino
Publicado: (2022)

Use of risankizumab in two HIV-positive patients with psoriasis
por: Maliyar, Khalad, et al.
Publicado: (2023)

Risankizumab in the treatment of psoriasis – literature review
por: Banaszczyk, Katarzyna
Publicado: (2019)

Successful treatment of psoriasis with risankizumab in a patient with telangiectasia macularis eruptiva perstans
por: Barber, Cara, et al.
Publicado: (2022)

New-onset systemic lupus erythematous in a patient receiving risankizumab for psoriasis
por: Barber, Cara, et al.
Publicado: (2022)

Successful treatment of palmoplantar psoriasis with chemical peeling and gentian violet
por: Bubley, Jeffrey A., et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of Risankizumab in Psoriasis Patients
por: Pang, Yinuo, et al.
Publicado: (2019)

A Case of Recalcitrant Circinate Generalized (Lapière) Psoriasis Successfully Treated with Risankizumab
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Ustekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis
por: Tonini, Annalisa, et al.
Publicado: (2019)

A case of secondary syphilis mimicking palmoplantar psoriasis in HIV infected patient
por: Bittencourt, Maraya de Jesus Semblano, et al.
Publicado: (2015)

Pustular Palmoplantar Psoriasis Successfully Treated with Nb-UVB Monochromatic Excimer Light: A Case-Report
por: Gianfaldoni, Serena, et al.
Publicado: (2017)

Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
por: Witjes, Han, et al.
Publicado: (2019)

Palmoplantar syphilis misdiagnosed and treated as palmoplantar psoriasis for 2 years
por: Solak, Berna, et al.
Publicado: (2016)

Nivolumab-induced psoriasis successfully treated with risankizumab-rzaa in a patient with stage III melanoma
por: Glinos, George D., et al.
Publicado: (2021)

Isolated Palmoplantar Lentiginosis
por: Alghubaywi, Faisal, et al.
Publicado: (2023)

Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Beating Palmoplantar Psoriasis Away
por: D’Souza, Paschal V
Publicado: (2012)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
por: Haugh, Isabel M, et al.
Publicado: (2018)

Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis
por: Reddy, Vidhatha, et al.
Publicado: (2020)

Twenty-five year-old female with sudden onset itchy skin eruption over her upper back and chest three weeks after starting a ketogenic diet
por: Alkeraye, Salim, et al.
Publicado: (2019)

Analysis of dermoscopic characteristic for the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema
por: Yu, Xiaoping, et al.
Publicado: (2021)

Simultaneous occurrence of Pyoderma Gangrenosum and Palmoplantar Pustular Psoriasis: Is it an association or coincidental findings?
por: Pukar, Chapagain, et al.
Publicado: (2020)

Palmoplantar Pustulosis: A Case Report
por: Dulski, Anne, et al.
Publicado: (2020)

Tozinameran: New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up: case report
Publicado: (2022)

Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
por: Blair, Hannah A.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ut99gqs86obmrcccvdj2itrqi